Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Eclat's specific reporting will not be made public

Eclat's specific reporting will not be made public

posted on Dec 28, 2009 10:20PM
This is the reply e-mail that I received from investor relations today.
The Company has provided information regarding the activities of the Eclat consulting team which have included the incorporation of their recommendation for recent management changes and the restructuring of the PDSG entity. The specific reporting and communications to our Board from Eclat will not be made public. Thank you for your inquiry,
Patriot Scientific Corporation
Investor Relations
So it looks as if we will not be informed of the specifics of Eclat's report.
Share
New Message
Please login to post a reply